Our future together with Pfizer will certainly be very strong with greater resources, a broader and deeper geographical presence, cutting edge research capabilities, and therapeutic categories where we have no presence today.
• Our footprint will nearly double, instantly;
• Our most important development projects can reach more markets, faster;
• Our leadership in key therapeutic areas will benefit with investment;
• Our people will have more opportunity to make a positive difference; and
• Most importantly, our products will reach more people who need them.